| Authors | H Rexer |
| Journal | Der Urologe. Ausg. A
(Urologe A)
Vol. 54
Issue 4
Pg. 555-7
(Apr 2015)
ISSN: 1433-0563 [Electronic] Germany |
| Vernacular Title | Studie zur Therapie beim metastasierten kastrationsresistenten Prostatakarzinom : Parallelgruppendesign zur Analyse der Wirksamkeit und Sicherheit von DCVAC/PCa vs. Placebo bei Männern mit metastasiertem kastrationsresistentem Prostatakarzinom und Eignung für die Erstlinienchemotherapie (VIABLE) - AUO-Studie AP 78/13. |
| PMID | 25758238
(Publication Type: Clinical Trial, Phase III, Journal Article, Randomized Controlled Trial)
|
| Chemical References |
- Antineoplastic Agents
- Cancer Vaccines
- Taxoids
- Docetaxel
|
| Topics |
- Antineoplastic Agents
(administration & dosage)
- Cancer Vaccines
(administration & dosage)
- Carcinoma
(diagnosis, epidemiology, therapy)
- Castration
- Combined Modality Therapy
- Dendritic Cells
(immunology)
- Docetaxel
- Double-Blind Method
- Drug-Related Side Effects and Adverse Reactions
(epidemiology)
- Humans
- Male
- Placebo Effect
- Prevalence
- Prostatic Neoplasms
(diagnosis, epidemiology, therapy)
- Risk Factors
- Taxoids
(administration & dosage)
- Treatment Failure
- Treatment Outcome
|
